Autor: |
R H, Wheeler, L J, Bricker, R B, Natale, S R, Baker |
Rok vydání: |
1984 |
Předmět: |
|
Zdroj: |
Cancer treatment reports. 68(2) |
ISSN: |
0361-5960 |
Popis: |
A phase II trial of ICRF-187 (1.0 g/m2/48 hours by continuous infusion every 3 weeks) was conducted in 25 patients with advanced squamous cell cancer of the head and neck. There were two partial responders for an overall response rate of 8%. Sixteen of the patients had not received prior chemotherapy and both responding patients were in this group. The major side effect of ICRF-187 was reversible leukopenia. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|